Glossary · 2026

The medical tourism
glossary, decoded.

Class A. JCI. NMPA. M-visa. MSC. CAR-T. VBP. 中西医结合. The acronyms and Chinese-character terms international patients keep encountering — defined plainly, with sources and links.

Quality & accreditation

Hospital classification.

Class A tertiary hospital三级甲等 / Sānjí jiǎděng三级甲等医院
China's highest hospital tier. Must score ≥900/1000 in NHC tri-annual audits covering patient safety, clinical quality, management and service. 1,795 such hospitals nationwide as of 2024.Read more
Class B tertiary hospital三级乙等三级乙等医院
Second-highest tier. Score 750–900 in NHC audits. Multi-specialty hospitals with strong inpatient care. ~3,200 nationwide.
Secondary hospital二级医院
District and county hospitals offering general inpatient and outpatient services. ~10,000+ nationwide.
JCIJoint Commission International
Leading international hospital accreditation body, originating from the US Joint Commission. 1,200+ standards across patient safety, infection control, governance. 3-year re-survey. Holds the gold standard for international medical tourism quality.Read more
NABHNational Accreditation Board for Hospitals (India)
Indian hospital accreditation body. ~1,000 hospitals certified. ISQua-endorsed. Frequently combined with JCI at top Indian centres.
MSQHMalaysian Society for Quality in Health
Malaysian hospital accreditation. Required for the Malaysia Healthcare Travel Council network.
ISQuaInternational Society for Quality in Health Care
Global meta-accreditor — accredits the accreditors. JCI, NABH and MSQH all carry ISQua endorsement.
International Patient DepartmentIPD · 国际部
Dedicated department within Class A or private hospitals serving international patients. English-speaking coordinators, simplified billing, expedited scheduling. Standard at top Chinese tertiary hospitals.
Private VIP wingVIP / 特需医疗
Premium service tier within Chinese public hospitals. Single-bed rooms, faster appointments, English coordinator. Pricing 30–60% above standard ward but typically still 50–70% below US private.

Who regulates what

Regulatory bodies & standards.

NHCNational Health Commission of China国家卫生健康委员会
China's central health regulator under the State Council. Oversees hospital classification, audit standards, public health policy, and medical professional licensing.
NMPANational Medical Products Administration国家药品监督管理局
China's drug and medical device regulator (formerly CFDA). Approves pharmaceuticals, devices, cellular therapies, and TCM herbal products. Approved 4 CAR-T products and Ruibosheng (first MSC drug, Jan 2025).
NATCMNational Administration of Traditional Chinese Medicine国家中医药管理局
China's regulator of Traditional Chinese Medicine practice and research. Oversees TCM hospital licensing, physician credentialling, and herbal pharmacopeia.Read more
VBPVolume-Based Procurement集中带量采购
China's national bulk-procurement programme that consolidates demand to drive aggressive pricing on devices and drugs. Reduced coronary stent prices from ¥13,000 to ~¥700 and joint prosthesis prices ~80%.Read more
ChiCTRChinese Clinical Trial Registry
China's official clinical trial registry. Hosts 14,000+ TCM trials and 2,794+ stem cell trials — among the world's largest registries.
GMPGood Manufacturing Practice
Manufacturing quality standard. NMPA-licensed cellular therapy facilities must maintain GMP-grade processing labs for stem cell, exosome and CAR-T products.
ICD-11International Classification of Diseases v11
WHO's official disease classification, in force since 2022. Chapter 26 formally recognises Traditional Chinese Medicine diagnostic terms — a major TCM-legitimacy milestone.

Procedures & cell types

Treatment & technology.

MSCMesenchymal Stem Cell间充质干细胞
Adult stem cells from bone marrow, adipose tissue, or umbilical cord. Most clinically used cell type. Strong evidence for OA, GVHD, autoimmune conditions.Read more
Autologous
From the patient's own body. Autologous MSC: harvested from the same patient. No rejection risk.
Allogeneic
From a donor. Allogeneic MSC: typically from screened umbilical cord tissue. Off-the-shelf availability.
iPSCInduced Pluripotent Stem Cell
Adult cells reprogrammed back to pluripotent state. Active research-stage protocols in China for Parkinson's, retinal disease, diabetes.
ExosomeExtracellular Vesicle
30–150 nm vesicles secreted by stem cells, carrying regenerative signalling molecules. Easier to standardise than cellular MSC. Used for systemic inflammation and dermatology.
CAR-TChimeric Antigen Receptor T-cell therapy
T cells genetically engineered to target a tumour antigen. NMPA approved 4 products in China for B-cell lymphoma, ALL, multiple myeloma. ~⅓ the US price.Read more
NK-cell therapyNatural Killer cell immunotherapy
Expansion of NK cells ex vivo and infusion. Used in oncology supportive care and selected autoimmune indications.
GVHDGraft-versus-Host Disease
Complication of allogeneic stem cell transplant where donor immune cells attack recipient tissue. NMPA-approved indication for Ruibosheng (China's first MSC drug, Jan 2025).
Proton therapy质子治疗
Radiotherapy using protons. Bragg-peak deposition spares healthy tissue. 8 clinical centres in China.Read more
Heavy-ion therapy重离子治疗
Carbon-ion radiotherapy with higher RBE than proton. Wuwei and Lanzhou centres in China.
IMRTIntensity-Modulated Radiation Therapy
Standard high-precision photon radiotherapy. Available at all major Chinese cancer centres.
Da Vinci surgical system
Robotic surgical platform by Intuitive Surgical. 400+ installed across Chinese hospitals.
Mako · ROSA
Robotic-assisted joint replacement systems by Stryker (Mako) and Zimmer Biomet (ROSA). Widely deployed at top Chinese orthopedic centres.Read more
TINAVI · TiRobot
Domestic Chinese spine surgery navigation robot, developed at Beijing Jishuitan. World's most-deployed spine robot.Read more
All-on-4 / All-on-6
Full-arch dental implant solutions using 4 or 6 implants supporting a fixed bridge. Same-trip immediate-load workflow standard at top Chinese dental clinics.Read more
ACDFAnterior Cervical Discectomy and Fusion
Standard cervical spine surgery for herniated disc or stenosis. 1–3 levels typical. ~$10,000–$16,000 in China.

TCM concepts

Traditional Chinese Medicine.

TCMTraditional Chinese Medicine中医
2,500-year-old medical system encompassing acupuncture, herbal medicine, tuina, moxibustion, cupping, qi gong. WHO ICD-11 recognised. 4,000+ licensed hospitals in China.Read more
Qi
Vital energy in TCM theory. The flow of qi through meridians underpins TCM diagnostic and treatment frameworks.
Yin–Yang阴阳
Complementary opposites in TCM theory. Health is the balance of yin and yang within the body.
Acupuncture针灸
Insertion of fine sterile needles at defined acupoints. WHO recognises 64 indications. NICE recommends for chronic tension headache and migraine.Read more
Moxibustion艾灸
Burning of mugwort (Artemisia argyi) above acupoints to warm meridians. Common in obstetrics, digestive and immunological conditions.
Tuina推拿
Therapeutic medical massage. Used for musculoskeletal pain, paediatric digestive issues, post-injury rehabilitation.
Cupping拔罐
Local suction therapy used in pain syndromes, respiratory conditions, athletic recovery.
Qi Gong气功
Movement, breath and meditative practice. Strongest evidence in stress, hypertension and cardiac rehabilitation.
Decoction汤剂
Raw herbs boiled at home. Strongest pharmacological effect; flexible to formula adjustments. The traditional form of Chinese herbal prescription.Read more
Granule颗粒剂
Pre-extracted, freeze-dried herbal preparation. NMPA-regulated for purity and potency. Most popular form for international patients.
Pattern differentiation辨证论治 / Biàn zhèng lùn zhì
TCM's individualised diagnostic framework — the same Western diagnosis can yield different herbal formulations depending on the patient's constitutional pattern.
Integrated Chinese-Western Medicine中西医结合
China's national clinical model combining Western pharmaceuticals/surgery with TCM. Dedicated 7-year medical degree. Strongest in oncology supportive care, post-stroke, IVF.Read more
Artemisinin青蒿素
Antimalarial derived from Artemisia annua. Tu Youyou received the 2015 Nobel Prize in Medicine for its discovery — TCM's most prominent contribution to global medicine.

Travel terms

Visa & immigration.

M-visaMedical Visa医疗签证 / 商务签证
China's dedicated visa for medical treatment and business purposes. Required for any medical tourism trip. Multi-entry options up to 10 years for some nationalities.Read more
L-visaTourist Visa旅游签证
China's tourist visa. Some short dental and minor cosmetic procedures can be done on L-visa; major procedures require M-visa.
S2 visa
Family-companion visa for those visiting a foreign relative receiving medical treatment in China. 30–180 days.
F-visa
Visit visa for non-business / non-tourism purposes. Used by accompanying physicians or research collaborators.
CVASCChinese Visa Application Service Center
Outsourced visa application centres operated by CIBT and others on behalf of Chinese embassies. Handle biometric collection and document submission.
COVA
China Online Visa Application — the official online form portal at cova.cs.mfa.gov.cn.
PSB Exit-Entry Administration公安局出入境管理处
China's Public Security Bureau visa-extension office. Handles in-country visa extensions for medical patients with hospital documentation.

Money

Cost & financial.

All-in pricing
Complete trip cost including procedure, hospitalisation, accommodation, coordinator, and standard implant — but excluding international airfare. Industry-standard for transparent medical tourism quotes.
Itemized quote
Written cost breakdown by line item: procedure fee, hospitalisation, anaesthesia, implants, post-op rehab. Top hospitals provide this in 5 business days; if a hospital won't itemize, walk away.
Coordinator fee
Service fee charged by medical-tourism coordinators (e.g. Panda Touring Care) covering hospital matching, visa support, interpreter, accommodation booking, and 12-month follow-up.
Pre-authorization
Written confirmation from your insurer that a specific procedure at a specific hospital is covered. Verbal confirmations are not binding — always require written pre-auth before booking.Read more
Self-insurance buffer
Set-aside funds (typically 20–30% of procedure cost) for unexpected extended stay, additional procedures, or out-of-pocket gaps. Recommended for all non-routine cases.

Found a term not in
the glossary?

Send us the question. We’ll add definitions readers ask for, and link them into deep-dive guides where useful.